Medical gas library

Standards

What is the NHRA medical device traceability programme?

Short answer

In Circular 5 of 2026, dated 15 March 2026, the NHRA announced a national traceability programme for medical devices and supplies on the Bahraini market, starting with manufacturers, authorised representatives, wholesalers and other exporters, with mandatory registration to open in April 2026.

The National Health Regulatory Authority (NHRA) of Bahrain addressed the circular to all medical device and medical supply manufacturers, authorised representatives, wholesalers and other exporters placing products on the Bahraini market. The circular says these stakeholders are the primary entry point of medical products into the national supply chain and are therefore the first participants required to engage with the framework.

What the programme is

The circular describes a digital regulatory platform to monitor medical devices and supplies throughout the supply chain. It says the programme supports regulatory visibility of products distributed in Bahrain, post market surveillance, and product traceability and recall management. It cites Law No. 38 of 2009 establishing the NHRA and Resolution No. 48 of 2020 on medical devices and products quality control among its legal basis.

Timeline in the circular

  • April 2026: opening of mandatory registration for authorised representatives, manufacturers, wholesalers and other exporters, as the circular states.
  • July 2026: planned launch of the traceability platform and the start of the regulatory requirements associated with the programme.
  • Later phases: healthcare institutions and other local economic operators will be incorporated progressively, with further guidance to follow.

The circular says registration procedures and technical onboarding will be communicated through subsequent circulars. Those later circulars were not read for this page, and the circular does not mention oxygen plants or medical gas equipment. It is a description of the NHRA's announcement, not regulatory advice; the regulator's own communications decide what applies today. Earlier amendments to the device quality rules are in How are medical devices regulated in Bahrain?.

More questions

Who is first required to take part in the NHRA traceability programme?

The circular says manufacturers, authorised representatives, wholesalers and other exporters placing products on the Bahraini market are the first participants.

Sources

Ultra Controlo figures come from its technical datasheets. Third-party facts were read at the source on the date shown.

Reviewed: · Ultra Controlo engineering · Markdown version

Related